| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $449.7M | -1.7% |
| R&D Expense | $26.9M | +2.8% |
| SG&A Expense | $238.6M | -4.2% |
| Operating Income | -$20.7M | +33.2% |
| Interest Expense | $18.9M | -6.7% |
| Pre-tax Income | -$23.6M | +53.6% |
| Income Tax | $10.2M | +96.8% |
| Net Income | -$25.8M | +93.4% |
| EPS (Basic) | -$0.94 | +93.7% |
| EPS (Diluted) | -$0.94 | +93.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.0M | +4.8% |
| Accounts Receivable | $65.2M | +0.1% |
| Inventory | $75.0M | -5.8% |
| Current Assets | $257.3M | -46.7% |
| Total Assets | $753.7M | -37.5% |
| Current Liabilities | $133.9M | -22.8% |
| Long-term Debt | $221.9M | -56.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.2M | -61.8% |
| Investing Cash Flow | $282.3M | +1960.4% |
| Financing Cash Flow | -$294.7M | -1048.1% |
| Total Liabilities |
| $372.0M |
| -53.3% |
| Stockholders' Equity | $381.7M | -6.8% |